Follow The Filings

ARTV position history

The shares of Artiva Biotherapeutics (ARTV) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 67,101 shares, $651K, 0.12% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders